Loading…

Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan

Pneumonia patients with wheezing due to influenza A(H1N1)pdm09 were frequently treated with systemic corticosteroids in Japan although systemic corticosteroid for critically ill patients with pneumonia caused by influenza A(H1N1)pdm09 has been controversial. Applicability of systemic corticosteroid...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2012-02, Vol.7 (2), p.e32280-e32280
Main Authors: Kudo, Koichiro, Takasaki, Jin, Manabe, Toshie, Uryu, Hideko, Yamada, Ritsuko, Kuroda, Emi, Kobayashi, Nobuyuki, Matsushita, Takeji
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c525t-9b81614c909e5525245aeade43a704c128ff15241c79d7da6be66500c9d407593
cites cdi_FETCH-LOGICAL-c525t-9b81614c909e5525245aeade43a704c128ff15241c79d7da6be66500c9d407593
container_end_page e32280
container_issue 2
container_start_page e32280
container_title PloS one
container_volume 7
creator Kudo, Koichiro
Takasaki, Jin
Manabe, Toshie
Uryu, Hideko
Yamada, Ritsuko
Kuroda, Emi
Kobayashi, Nobuyuki
Matsushita, Takeji
description Pneumonia patients with wheezing due to influenza A(H1N1)pdm09 were frequently treated with systemic corticosteroids in Japan although systemic corticosteroid for critically ill patients with pneumonia caused by influenza A(H1N1)pdm09 has been controversial. Applicability of systemic corticosteroid treatment needs to be evaluated. We retrospectively reviewed 89 subjects who were diagnosed with influenza A(H1N1)pdm09 and admitted to a national hospital, Tokyo during the pandemic period. The median age of subjects (45 males) was 8 years (range, 0-71). All subjects were treated with antiviral agents and the median time from symptom onset to initiation of antiviral agents was 2 days (range, 0-7). Subjects were classified into four groups: upper respiratory tract infection, wheezing illness, pneumonia with wheezing, and pneumonia without wheezing. The characteristics of each group was evaluated. A history of asthma was found more frequently in the wheezing illness (55.6%) and pneumonia with wheezing (43.3%) groups than in the other two groups (p = 0.017). Corticosteroid treatment was assessed among subjects with pneumonia. Oxygen saturation was lower in subjects receiving corticosteroids (steroid group) than in subjects not receiving corticosteroids (no-steroid group) (p
doi_str_mv 10.1371/journal.pone.0032280
format article
fullrecord <record><control><sourceid>proquest_plos_</sourceid><recordid>TN_cdi_plos_journals_1333200468</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0b54ca3f40944d6abdca893f1a7a5ced</doaj_id><sourcerecordid>926644677</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-9b81614c909e5525245aeade43a704c128ff15241c79d7da6be66500c9d407593</originalsourceid><addsrcrecordid>eNptUk1vEzEUXCEQLYV_gMASB-CQ4O9dX5CqqtCiCg7A2XqxvYmjXXtr77ZKf0R_Mw5JqxZxsj1v3jy_0VTVa4LnhNXk0zpOKUA3H2Jwc4wZpQ1-Uh0SxehMUsyePrgfVC9yXmMsWCPl8-qAUqYYU-Kwuv25yaPrvUEmptGbWF4pepsRBIscpG6DwPY--DwmGH0MKLalNvorn6BDsHRhzKiNCQ3BTX0MHtC1H1cIzDQ6dL1y7saHJbKTQ2NEPrTd5MINoOMPZ-Q7-TjYHqsCo28wQHhZPWuhy-7V_jyqfn85_XVyNrv48fX85PhiZgQV40wtGiIJNworJwpCuQAH1nEGNeaG0KZtSUGJqZWtLciFk1JgbJTluBaKHVVvd7pDF7PeW5k1YYxRjLlsCuN8x7AR1npIvoe00RG8_gvEtNSwNaxzGi8EN8BajhXnVsLCGmgUawnUIIyzRevzftq06J01xbLi3SPRx5XgV3oZrzSjCguBi8D7vUCKl5PLo-59Nq7rILg4Za2olJzLui7Md_8w_78c37FMijkn197_hWC9Tdddl96mS-_TVdrePNzjvukuTuwPdp3PvA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1333200468</pqid></control><display><type>article</type><title>Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan</title><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><creator>Kudo, Koichiro ; Takasaki, Jin ; Manabe, Toshie ; Uryu, Hideko ; Yamada, Ritsuko ; Kuroda, Emi ; Kobayashi, Nobuyuki ; Matsushita, Takeji</creator><creatorcontrib>Kudo, Koichiro ; Takasaki, Jin ; Manabe, Toshie ; Uryu, Hideko ; Yamada, Ritsuko ; Kuroda, Emi ; Kobayashi, Nobuyuki ; Matsushita, Takeji</creatorcontrib><description>Pneumonia patients with wheezing due to influenza A(H1N1)pdm09 were frequently treated with systemic corticosteroids in Japan although systemic corticosteroid for critically ill patients with pneumonia caused by influenza A(H1N1)pdm09 has been controversial. Applicability of systemic corticosteroid treatment needs to be evaluated. We retrospectively reviewed 89 subjects who were diagnosed with influenza A(H1N1)pdm09 and admitted to a national hospital, Tokyo during the pandemic period. The median age of subjects (45 males) was 8 years (range, 0-71). All subjects were treated with antiviral agents and the median time from symptom onset to initiation of antiviral agents was 2 days (range, 0-7). Subjects were classified into four groups: upper respiratory tract infection, wheezing illness, pneumonia with wheezing, and pneumonia without wheezing. The characteristics of each group was evaluated. A history of asthma was found more frequently in the wheezing illness (55.6%) and pneumonia with wheezing (43.3%) groups than in the other two groups (p = 0.017). Corticosteroid treatment was assessed among subjects with pneumonia. Oxygen saturation was lower in subjects receiving corticosteroids (steroid group) than in subjects not receiving corticosteroids (no-steroid group) (p&lt;0.001). The steroid group required greater oxygen supply than the no-steroid group (p&lt;0.001). No significant difference was found by the Kaplan-Meier method between the steroid and the no-steroid groups in hours to fever alleviation from the initiation of antiviral agents and hospitalization days. In logistic regression analysis, wheezing, pneumonia and oxygen saturation were independent factors associated with using systemic corticosteroids. Patients with wheezing and a history of asthma were frequently found in the study subjects. Systemic corticosteroids together with early administration of antiviral agents to pneumonia with wheezing and possibly without wheezing did not result in negative clinical outcomes and may prevent progression to severe pneumonia in this study population.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0032280</identifier><identifier>PMID: 22393395</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adolescent ; Adrenal Cortex Hormones - therapeutic use ; Adult ; Aged ; Antiviral agents ; Antiviral Agents - administration &amp; dosage ; Antiviral drugs ; Asthma ; Biology ; Child ; Child, Preschool ; Corticoids ; Corticosteroids ; Disease prevention ; Drug Administration Schedule ; Female ; Fever ; Hospitalization ; Humans ; Illnesses ; Infant ; Infant, Newborn ; Infections ; Infectious diseases ; Influenza ; Influenza A ; Influenza A Virus, H1N1 Subtype - metabolism ; Influenza, Human - drug therapy ; Influenza, Human - virology ; Laboratories ; Male ; Males ; Medicine ; Middle Aged ; Morality ; Oxygen ; Oxygen content ; Pandemics ; Patients ; Pneumonia ; Pneumonia - drug therapy ; Population studies ; Regression Analysis ; Respiratory Sounds ; Respiratory tract ; Respiratory tract diseases ; Retrospective Studies ; Saturation ; Steroids ; Swine flu ; Viruses ; Wheezing</subject><ispartof>PloS one, 2012-02, Vol.7 (2), p.e32280-e32280</ispartof><rights>2012 Kudo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Kudo et al. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-9b81614c909e5525245aeade43a704c128ff15241c79d7da6be66500c9d407593</citedby><cites>FETCH-LOGICAL-c525t-9b81614c909e5525245aeade43a704c128ff15241c79d7da6be66500c9d407593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1333200468/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1333200468?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22393395$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kudo, Koichiro</creatorcontrib><creatorcontrib>Takasaki, Jin</creatorcontrib><creatorcontrib>Manabe, Toshie</creatorcontrib><creatorcontrib>Uryu, Hideko</creatorcontrib><creatorcontrib>Yamada, Ritsuko</creatorcontrib><creatorcontrib>Kuroda, Emi</creatorcontrib><creatorcontrib>Kobayashi, Nobuyuki</creatorcontrib><creatorcontrib>Matsushita, Takeji</creatorcontrib><title>Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Pneumonia patients with wheezing due to influenza A(H1N1)pdm09 were frequently treated with systemic corticosteroids in Japan although systemic corticosteroid for critically ill patients with pneumonia caused by influenza A(H1N1)pdm09 has been controversial. Applicability of systemic corticosteroid treatment needs to be evaluated. We retrospectively reviewed 89 subjects who were diagnosed with influenza A(H1N1)pdm09 and admitted to a national hospital, Tokyo during the pandemic period. The median age of subjects (45 males) was 8 years (range, 0-71). All subjects were treated with antiviral agents and the median time from symptom onset to initiation of antiviral agents was 2 days (range, 0-7). Subjects were classified into four groups: upper respiratory tract infection, wheezing illness, pneumonia with wheezing, and pneumonia without wheezing. The characteristics of each group was evaluated. A history of asthma was found more frequently in the wheezing illness (55.6%) and pneumonia with wheezing (43.3%) groups than in the other two groups (p = 0.017). Corticosteroid treatment was assessed among subjects with pneumonia. Oxygen saturation was lower in subjects receiving corticosteroids (steroid group) than in subjects not receiving corticosteroids (no-steroid group) (p&lt;0.001). The steroid group required greater oxygen supply than the no-steroid group (p&lt;0.001). No significant difference was found by the Kaplan-Meier method between the steroid and the no-steroid groups in hours to fever alleviation from the initiation of antiviral agents and hospitalization days. In logistic regression analysis, wheezing, pneumonia and oxygen saturation were independent factors associated with using systemic corticosteroids. Patients with wheezing and a history of asthma were frequently found in the study subjects. Systemic corticosteroids together with early administration of antiviral agents to pneumonia with wheezing and possibly without wheezing did not result in negative clinical outcomes and may prevent progression to severe pneumonia in this study population.</description><subject>Adolescent</subject><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Adult</subject><subject>Aged</subject><subject>Antiviral agents</subject><subject>Antiviral Agents - administration &amp; dosage</subject><subject>Antiviral drugs</subject><subject>Asthma</subject><subject>Biology</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Corticoids</subject><subject>Corticosteroids</subject><subject>Disease prevention</subject><subject>Drug Administration Schedule</subject><subject>Female</subject><subject>Fever</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Illnesses</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Influenza</subject><subject>Influenza A</subject><subject>Influenza A Virus, H1N1 Subtype - metabolism</subject><subject>Influenza, Human - drug therapy</subject><subject>Influenza, Human - virology</subject><subject>Laboratories</subject><subject>Male</subject><subject>Males</subject><subject>Medicine</subject><subject>Middle Aged</subject><subject>Morality</subject><subject>Oxygen</subject><subject>Oxygen content</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Pneumonia</subject><subject>Pneumonia - drug therapy</subject><subject>Population studies</subject><subject>Regression Analysis</subject><subject>Respiratory Sounds</subject><subject>Respiratory tract</subject><subject>Respiratory tract diseases</subject><subject>Retrospective Studies</subject><subject>Saturation</subject><subject>Steroids</subject><subject>Swine flu</subject><subject>Viruses</subject><subject>Wheezing</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptUk1vEzEUXCEQLYV_gMASB-CQ4O9dX5CqqtCiCg7A2XqxvYmjXXtr77ZKf0R_Mw5JqxZxsj1v3jy_0VTVa4LnhNXk0zpOKUA3H2Jwc4wZpQ1-Uh0SxehMUsyePrgfVC9yXmMsWCPl8-qAUqYYU-Kwuv25yaPrvUEmptGbWF4pepsRBIscpG6DwPY--DwmGH0MKLalNvorn6BDsHRhzKiNCQ3BTX0MHtC1H1cIzDQ6dL1y7saHJbKTQ2NEPrTd5MINoOMPZ-Q7-TjYHqsCo28wQHhZPWuhy-7V_jyqfn85_XVyNrv48fX85PhiZgQV40wtGiIJNworJwpCuQAH1nEGNeaG0KZtSUGJqZWtLciFk1JgbJTluBaKHVVvd7pDF7PeW5k1YYxRjLlsCuN8x7AR1npIvoe00RG8_gvEtNSwNaxzGi8EN8BajhXnVsLCGmgUawnUIIyzRevzftq06J01xbLi3SPRx5XgV3oZrzSjCguBi8D7vUCKl5PLo-59Nq7rILg4Za2olJzLui7Md_8w_78c37FMijkn197_hWC9Tdddl96mS-_TVdrePNzjvukuTuwPdp3PvA</recordid><startdate>20120229</startdate><enddate>20120229</enddate><creator>Kudo, Koichiro</creator><creator>Takasaki, Jin</creator><creator>Manabe, Toshie</creator><creator>Uryu, Hideko</creator><creator>Yamada, Ritsuko</creator><creator>Kuroda, Emi</creator><creator>Kobayashi, Nobuyuki</creator><creator>Matsushita, Takeji</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20120229</creationdate><title>Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan</title><author>Kudo, Koichiro ; Takasaki, Jin ; Manabe, Toshie ; Uryu, Hideko ; Yamada, Ritsuko ; Kuroda, Emi ; Kobayashi, Nobuyuki ; Matsushita, Takeji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-9b81614c909e5525245aeade43a704c128ff15241c79d7da6be66500c9d407593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Adult</topic><topic>Aged</topic><topic>Antiviral agents</topic><topic>Antiviral Agents - administration &amp; dosage</topic><topic>Antiviral drugs</topic><topic>Asthma</topic><topic>Biology</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Corticoids</topic><topic>Corticosteroids</topic><topic>Disease prevention</topic><topic>Drug Administration Schedule</topic><topic>Female</topic><topic>Fever</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Illnesses</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Influenza</topic><topic>Influenza A</topic><topic>Influenza A Virus, H1N1 Subtype - metabolism</topic><topic>Influenza, Human - drug therapy</topic><topic>Influenza, Human - virology</topic><topic>Laboratories</topic><topic>Male</topic><topic>Males</topic><topic>Medicine</topic><topic>Middle Aged</topic><topic>Morality</topic><topic>Oxygen</topic><topic>Oxygen content</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Pneumonia</topic><topic>Pneumonia - drug therapy</topic><topic>Population studies</topic><topic>Regression Analysis</topic><topic>Respiratory Sounds</topic><topic>Respiratory tract</topic><topic>Respiratory tract diseases</topic><topic>Retrospective Studies</topic><topic>Saturation</topic><topic>Steroids</topic><topic>Swine flu</topic><topic>Viruses</topic><topic>Wheezing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kudo, Koichiro</creatorcontrib><creatorcontrib>Takasaki, Jin</creatorcontrib><creatorcontrib>Manabe, Toshie</creatorcontrib><creatorcontrib>Uryu, Hideko</creatorcontrib><creatorcontrib>Yamada, Ritsuko</creatorcontrib><creatorcontrib>Kuroda, Emi</creatorcontrib><creatorcontrib>Kobayashi, Nobuyuki</creatorcontrib><creatorcontrib>Matsushita, Takeji</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kudo, Koichiro</au><au>Takasaki, Jin</au><au>Manabe, Toshie</au><au>Uryu, Hideko</au><au>Yamada, Ritsuko</au><au>Kuroda, Emi</au><au>Kobayashi, Nobuyuki</au><au>Matsushita, Takeji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2012-02-29</date><risdate>2012</risdate><volume>7</volume><issue>2</issue><spage>e32280</spage><epage>e32280</epage><pages>e32280-e32280</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Pneumonia patients with wheezing due to influenza A(H1N1)pdm09 were frequently treated with systemic corticosteroids in Japan although systemic corticosteroid for critically ill patients with pneumonia caused by influenza A(H1N1)pdm09 has been controversial. Applicability of systemic corticosteroid treatment needs to be evaluated. We retrospectively reviewed 89 subjects who were diagnosed with influenza A(H1N1)pdm09 and admitted to a national hospital, Tokyo during the pandemic period. The median age of subjects (45 males) was 8 years (range, 0-71). All subjects were treated with antiviral agents and the median time from symptom onset to initiation of antiviral agents was 2 days (range, 0-7). Subjects were classified into four groups: upper respiratory tract infection, wheezing illness, pneumonia with wheezing, and pneumonia without wheezing. The characteristics of each group was evaluated. A history of asthma was found more frequently in the wheezing illness (55.6%) and pneumonia with wheezing (43.3%) groups than in the other two groups (p = 0.017). Corticosteroid treatment was assessed among subjects with pneumonia. Oxygen saturation was lower in subjects receiving corticosteroids (steroid group) than in subjects not receiving corticosteroids (no-steroid group) (p&lt;0.001). The steroid group required greater oxygen supply than the no-steroid group (p&lt;0.001). No significant difference was found by the Kaplan-Meier method between the steroid and the no-steroid groups in hours to fever alleviation from the initiation of antiviral agents and hospitalization days. In logistic regression analysis, wheezing, pneumonia and oxygen saturation were independent factors associated with using systemic corticosteroids. Patients with wheezing and a history of asthma were frequently found in the study subjects. Systemic corticosteroids together with early administration of antiviral agents to pneumonia with wheezing and possibly without wheezing did not result in negative clinical outcomes and may prevent progression to severe pneumonia in this study population.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>22393395</pmid><doi>10.1371/journal.pone.0032280</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2012-02, Vol.7 (2), p.e32280-e32280
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1333200468
source Publicly Available Content (ProQuest); PubMed Central
subjects Adolescent
Adrenal Cortex Hormones - therapeutic use
Adult
Aged
Antiviral agents
Antiviral Agents - administration & dosage
Antiviral drugs
Asthma
Biology
Child
Child, Preschool
Corticoids
Corticosteroids
Disease prevention
Drug Administration Schedule
Female
Fever
Hospitalization
Humans
Illnesses
Infant
Infant, Newborn
Infections
Infectious diseases
Influenza
Influenza A
Influenza A Virus, H1N1 Subtype - metabolism
Influenza, Human - drug therapy
Influenza, Human - virology
Laboratories
Male
Males
Medicine
Middle Aged
Morality
Oxygen
Oxygen content
Pandemics
Patients
Pneumonia
Pneumonia - drug therapy
Population studies
Regression Analysis
Respiratory Sounds
Respiratory tract
Respiratory tract diseases
Retrospective Studies
Saturation
Steroids
Swine flu
Viruses
Wheezing
title Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T06%3A20%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Systemic%20corticosteroids%20and%20early%20administration%20of%20antiviral%20agents%20for%20pneumonia%20with%20acute%20wheezing%20due%20to%20influenza%20A(H1N1)pdm09%20in%20Japan&rft.jtitle=PloS%20one&rft.au=Kudo,%20Koichiro&rft.date=2012-02-29&rft.volume=7&rft.issue=2&rft.spage=e32280&rft.epage=e32280&rft.pages=e32280-e32280&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0032280&rft_dat=%3Cproquest_plos_%3E926644677%3C/proquest_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c525t-9b81614c909e5525245aeade43a704c128ff15241c79d7da6be66500c9d407593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1333200468&rft_id=info:pmid/22393395&rfr_iscdi=true